腸重積症の世界市場レポート 2024年

腸重積症の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には4.5%の年間複合成長率（CAGR）で53億米ドルに成長すると予想されます。予測期間で予想される成長は、進行中の医学教育の取り組み、小児ワクチン接種プログラム、小児ヘルスケアにおける世界の取り組み、術後ケアの重視、小児消化器調査の需要の増加、遠隔医療と遠隔ヘルスケアアクセスの採用に起因すると考えられます。予測期間中に予想される主な動向としては、画像診断の進歩、低侵襲治療アプローチの促進、小児特有の介入の開発、病因と危険因子の調査、世界の疫学研究、ワクチン接種プログラムの実施、予防接種の統合などが挙げられます。診断や相談のための遠隔医療。

予想される腸疾患の発生率の増加は、将来の腸重積症市場の成長を促進する態勢が整っています。腸疾患には、消化器系で重要な役割を果たす腸の正常な機能に影響を与えるさまざまな病状が含まれます。炎症性腸疾患や胃腸がんなどの腸疾患の発生が増加すると、早期診断、治療選択肢の改善、腸重積症を持つ患者へのサポートの強化につながり、最終的には健康状態の改善に貢献する可能性があります。たとえば、2023年 1月の米国がん協会（ACS）のデータによると、米国の消化器がんは3.18%増加し、2021年の338,090件と比較して348,840件に達しました。 腸疾患件数の増加は、腸重積症市場の成長を促すと予想されます。

腸重積症市場の成長は、ヘルスケア支出の増加によってさらに促進されます。ヘルスケア支出とは、特定の地域、国、または組織内のヘルスケア部門に割り当てられた財源の合計を指します。 腸重積症などの症状を含む医療ニーズに対処するための財源の割り当ては、医療介入、診断手順、および潜在的な外科的治療への支出の増加につながり、ヘルスケア支出全体に影響を与えます。たとえば、2023年 3月、米国医師協会は、2021年の米国の医療支出は2.7%増加し、4兆3,000億米ドル、つまり一人当たり12,914ドルに達したと報告しました。したがって、ヘルスケア支出の増加傾向は、腸重積症市場の成長の主要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の腸重積市場促進要因と制約要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の腸重積症の市場規模実績と成長、2018年～2023年
• 世界の腸重積症市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の腸重積市場、タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 特発性腸重積症
• 二次性腸重積症
• 世界の腸重積症市場、治療別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 浣腸の削減
• 手術
• その他の治療
• 世界の腸重積市場、診断別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• バリウム浣腸
• 超音波
• X線
• コンピュータ断層撮影（CT）
• 世界の腸重積市場、エンドユーザー別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 病院
• クリニック
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の腸重積市場、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
• 世界の腸重積市場、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腸重積症市場の競合情勢
• 腸重積市場の企業プロファイル
  • Pfizer Inc.
  • Merck &Co. Inc
  • Bayer AG
  • Novartis AG
  • Bristol-Myers Squibb Company

第31章 その他の主要および革新的な企業

• Abbott Laboratories
• Sanofi SA
• GlaxoSmithKline plc
• Stryker Corporation
• Boston Scientific Corporation
• Biogen Inc.
• Olympus Corporation
• GE HealthCare Technologies Inc.
• Steris Plc
• Cook Medical LLC
• Shimadzu Corporation
• Carestream Health
• CONMED Corporation
• Janssen Pharmaceuticals Inc.
• EndoChoice Holdings Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Intussusception is a medical condition wherein one part of the intestine slides into an adjacent section, causing a blockage in the flow of food, fluids, and gas through the affected portion. This condition manifests with symptoms such as severe abdominal pain, vomiting, and bloody stools. Diagnosis of intussusception typically relies on symptoms, physical examination, and imaging tests.

There are two main types of intussusception are idiopathic intussusception and secondary intussusception. Idiopathic intussusception involves the telescoping or invagination of one part of the intestine into another, resulting in a blockage or obstruction that can often be treated non-surgically through procedures such as pneumatic or hydrostatic reduction. Treatment methods include enema reduction, surgery, and others, with diagnostic approaches such as barium enema, ultrasound, and X-ray. These services are generally provided by hospitals, clinics, and other medical facilities.

The intussusception market research report is one of a series of new reports from The Business Research Company that provides intussusception market statistics, including intussusception industry global market size, regional shares, competitors with an intussusception market share, detailed intussusception market segments, market trends and opportunities, and any further data you may need to thrive in the intussusception industry. This intussusception market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intussusception market size has grown strongly in recent years. It will grow from $4.22 billion in 2023 to $4.45 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth observed in the historical period can be attributed to several factors, including enhanced diagnostic capabilities, increased awareness and education, global expansion of healthcare infrastructure, investments in research and development, and collaborative efforts among healthcare entities.

The intussusception market size is expected to see steady growth in the next few years. It will grow to $5.3 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The anticipated growth in the forecast period can be attributed to ongoing medical education initiatives, pediatric vaccination programs, global endeavors in pediatric healthcare, an emphasis on postoperative care, an increasing demand for pediatric gastrointestinal research, and the adoption of telemedicine and remote healthcare access. Major trends expected in the forecast period include advancements in diagnostic imaging, the promotion of minimally invasive treatment approaches, the development of pediatric-specific interventions, research on etiology and risk factors, global epidemiological studies, the implementation of vaccination programs, and the integration of telemedicine for diagnosis and consultation.

The anticipated rise in the incidence of intestinal disorders is poised to drive the growth of the intussusception market in the future. Intestinal disorders encompass various medical conditions affecting the normal functioning of the intestines, which play a crucial role in the digestive system. The increasing occurrence of intestinal disorders, such as inflammatory bowel disease and gastrointestinal cancers, can lead to earlier diagnoses, improved treatment options, and enhanced support for patients with intussusception, ultimately contributing to better health outcomes. For instance, data from the American Cancer Society (ACS) in January 2023 revealed a 3.18% increase in gastrointestinal cancers in the United States, reaching 348,840 cases compared to 338,090 in 2021. Therefore, the rising incidence of intestinal disorders is expected to drive the growth of the intussusception market.

The growth of the intussusception market is further propelled by the increase in healthcare spending. Healthcare spending refers to the total financial resources allocated to the healthcare sector within a specific region, country, or organization. The allocation of financial resources to address medical needs, including conditions such as intussusception, leads to increased spending on medical interventions, diagnostic procedures, and potential surgical treatments, impacting overall healthcare expenditure. For instance, in March 2023, the American Medical Association reported that health spending in the United States increased by 2.7% in 2021, reaching $4.3 trillion or $12,914 per capita. Therefore, the upward trend in healthcare spending is a key driver for the growth of the intussusception market.

The anticipated impact of stringent regulatory policies governing the development and approval of diagnostic tools and treatment options is expected to restrain the growth of the intussusception market. Stringent regulations can pose challenges by imposing rigorous requirements, potentially causing delays in market entry and increasing the overall cost and complexity of introducing new solutions. For example, in July 2022, the World Health Organization (WHO) established the Expert Review Panel for Diagnostics (ERPD) to assist procurers and national programs in evaluating the risks associated with diagnostic tests, especially those that have not undergone stringent regulatory authority assessments. This mechanism aims to ensure the safety and efficacy of diagnostic tools. Consequently, the stringent regulatory policies governing the development and approval of diagnostic tools and treatment options may impede the growth of the intussusception market.

Major companies in the intestinal pseudo-obstruction treatment market are actively involved in developing innovative drug therapies, such as NHE3 inhibitor treatment therapy, to provide reliable services to customers. NHE3 inhibitor treatment therapy involves the inhibition of the Sodium-Proton-Exchanger subtype 3 (NHE3) in the gut. For example, in April 2022, Ardelyx Inc., a US-based biopharmaceutical company, introduced IBSRELA, an NHE3 inhibitor treatment designed for irritable bowel syndrome with constipation (IBS-C) in adults. This therapy has the potential to improve gastrointestinal motility by inhibiting or blocking the activity of the Sodium-Hydrogen Exchanger 3 (NHE3) protein. The approval of IBSRELA was based on two Phase 3 trials involving over 1,200 IBS-C patients. The treatment significantly improved abdominal pain and bowel movements, meeting the primary endpoint. Notably, improvements were observed as early as Week 1 and sustained for 26 weeks in the long-term trial.

In March 2022, Pfizer Inc., a prominent US-based pharmaceutical manufacturing company, acquired Arena Pharmaceuticals, Inc. This acquisition is part of Pfizer's strategic efforts to bolster its portfolio of therapeutic candidates at various stages of development within the field of gastroenterology. Arena Pharmaceuticals, Inc., a US-based clinical-stage company, is actively involved in developing treatments for intestinal diseases, including intussusception (bowel obstruction). The acquisition aligns with Pfizer's commitment to advancing research and development in gastrointestinal therapeutics.

Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.

North America was the largest region in the intussusception market in 2023. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intussusception market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intussusception market consists of revenues earned by entities that provide diagnostic services such as clinical examination, magnetic resonance imaging, exploratory laparoscopy, or laparotomy that help in diagnosing and managing intussusception as a medical condition. The market value includes the value of related goods sold by the service provider or included within the service offering. The intussusception market also includes sales of drugs such as acetaminophen with codeine and ibuprofen. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intussusception Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intussusception market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intussusception ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intussusception market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Idiopathic Intussusception; Secondary Intussusception
• 2) By Treatment: Enema Reduction; Surgery; Other Treatment
• 3) By Diagnosis: Barium Enema; Ultrasound; X-Ray; Computerized Tomography (CT)
• 4) By End-User: Hospitals; Clinics; Other End-User
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc; Bayer AG; Novartis AG; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intussusception Market Characteristics

3. Intussusception Market Trends And Strategies

4. Intussusception Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Intussusception Market Size and Growth

• 5.1. Global Intussusception Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Intussusception Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Intussusception Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Intussusception Market Segmentation

• 6.1. Global Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Idiopathic Intussusception
• Secondary Intussusception
• 6.2. Global Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Enema Reduction
• Surgery
• Other Treatment
• 6.3. Global Intussusception Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Barium Enema
• Ultrasound
• X-Ray
• Computerized Tomography (CT)
• 6.4. Global Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Other End-User

7. Intussusception Market Regional And Country Analysis

• 7.1. Global Intussusception Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Intussusception Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Intussusception Market

• 8.1. Asia-Pacific Intussusception Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Intussusception Market

• 9.1. China Intussusception Market Overview
• 9.2. China Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Intussusception Market

• 10.1. India Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Intussusception Market

• 11.1. Japan Intussusception Market Overview
• 11.2. Japan Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Intussusception Market

• 12.1. Australia Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Intussusception Market

• 13.1. Indonesia Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Intussusception Market

• 14.1. South Korea Intussusception Market Overview
• 14.2. South Korea Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Intussusception Market

• 15.1. Western Europe Intussusception Market Overview
• 15.2. Western Europe Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Intussusception Market

• 16.1. UK Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Intussusception Market

• 17.1. Germany Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Intussusception Market

• 18.1. France Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Intussusception Market

• 19.1. Italy Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Intussusception Market

• 20.1. Spain Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Intussusception Market

• 21.1. Eastern Europe Intussusception Market Overview
• 21.2. Eastern Europe Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Intussusception Market

• 22.1. Russia Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Intussusception Market

• 23.1. North America Intussusception Market Overview
• 23.2. North America Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Intussusception Market

• 24.1. USA Intussusception Market Overview
• 24.2. USA Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Intussusception Market

• 25.1. Canada Intussusception Market Overview
• 25.2. Canada Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Intussusception Market

• 26.1. South America Intussusception Market Overview
• 26.2. South America Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Intussusception Market

• 27.1. Brazil Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Intussusception Market

• 28.1. Middle East Intussusception Market Overview
• 28.2. Middle East Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Intussusception Market

• 29.1. Africa Intussusception Market Overview
• 29.2. Africa Intussusception Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Intussusception Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Intussusception Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Intussusception Market Competitive Landscape And Company Profiles

• 30.1. Intussusception Market Competitive Landscape
• 30.2. Intussusception Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck & Co. Inc
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Bayer AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Novartis AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bristol-Myers Squibb Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Intussusception Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Sanofi S.A.
• 31.3. GlaxoSmithKline plc
• 31.4. Stryker Corporation
• 31.5. Boston Scientific Corporation
• 31.6. Biogen Inc.
• 31.7. Olympus Corporation
• 31.8. GE HealthCare Technologies Inc.
• 31.9. Steris Plc
• 31.10. Cook Medical LLC
• 31.11. Shimadzu Corporation
• 31.12. Carestream Health
• 31.13. CONMED Corporation
• 31.14. Janssen Pharmaceuticals Inc.
• 31.15. EndoChoice Holdings Inc.

32. Global Intussusception Market Competitive Benchmarking

33. Global Intussusception Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Intussusception Market

35. Intussusception Market Future Outlook and Potential Analysis

• 35.1 Intussusception Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Intussusception Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Intussusception Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer